Prezzo Delle Azioni
3.39
Cambio Giornaliero
-0.27 -7.38%
Mensile
-29.23%
Annuale
110.56%
Q1 Previsione
3.84




Costo Del Venduto Cambiamento Data
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Agios Pharmaceuticals USD 1.88M 199K 2025-12
Akebia Therapeutics USD 8.13M 2.41M 2025-03
Almirall EUR 191.5M 2.29M 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amarin USD 16.89M 18.51M 2025-03
Ardelyx USD 3.98M 10.84M 2025-09
Astellas Pharma JPY 149.13B 10.88B 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Coherus Biosciences USD 2.65M 31.2M 2025-03
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Exact Sciences USD 266.81M 18.18M 2025-09
Halozyme Therapeutics USD 102.15M 29.14M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Karyopharm Therapeutics USD 37.43M 2.41M 2024-09
Lexicon Pharmaceuticals USD 17.81M 3.41M 2024-06
MacroGenics USD 44.3M 5.4M 2025-09
Moderna USD 452M 245M 2025-12
Myriad Genetics USD 61.9M 600K 2025-09
Pacira USD 54.62M 6.02M 2025-12
PTC Therapeutics USD 16.3M 7.02M 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Takeda JPY 401.15B 184.07B 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12


Ironwood Pharmaceuticals Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.